Conatus Pharma - Rebound 2016...
Die 50 Mio. ist eine Vorabzahlung oder auch Meilensteinzahlung...
http://www.finanzen.ch/nachrichten/Aktien/...t-mit-Conatus-1001617100
Conatus has entered into a collaboration agreement with Novartis to develop their lead drug emricasan.
Conatus has received $50 million up front, and potential for up to $650 million in milestone payments down the line.
Taking a look at what's in store for Conatus over the next few years.
http://seekingalpha.com/article/...-emerges-novartis-nash-field-heats
Das gibt's ne fette Weihnachtsgans und ne Extraflasche Champagner :) :)
...durchschnittliches Kursziel bei 16 $....nur buy Empfehlungen..on the long kann man da nicht viel falsch machen..
Conatus bulls see several hundred percent more upside